Molecular structure of Hyaluronic Acid, Sodium Salt, CAS Number: 9067-32-7
Hyaluronic Acid, Sodium Salt (CAS 9067-32-7)
See product citations (1)
Alternate Names:
also known as HA; Hyaluronan; Hyaluronate; Hyasis 850P; Sodium hyaluronate; Hyaluronin; Hyalgan; Healon
Application:
Hyaluronic Acid, Sodium Salt is a natural high-viscosity mucopolysaccharide with alternating β1,3-glucuronidic and β1,4-glucosaminidic bonds
CAS Number:
9067-32-7
Molecular Formula:
[C14H22NNaO11]n
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Hyaluronic Acid, Sodium Salt (HA), from Streptococcus sp is a natural high-viscosity mucopolysaccharide with alternating beta1,3-glucuronidic and beta1,4-glucosaminidic bonds. Principal glycosaminoglycan in connective tissue fluids. The molecular weight of Hyaluronic Acid, Sodium Salt is in the range of 5.0 x 105 - 1.2 x 106, as calculated from its limiting viscosity. Hyaluronic Acid, Sodium Salt is an anionic linear glycosaminoglycan composed of monomers of glurcuronic acid and N-acetylglucosamine. It is widely distributed throughout connective and epithelial tissue and is a chief component of the extracellular matrix. Hyaluronic Acid, Sodium Salt contributes to cellular proliferation and may contribute to the progression of malignant tumors.
Hyaluronic Acid, Sodium Salt (CAS 9067-32-7) References
- [Clinical application of Bionect (Hyaluronic Acid Sodium Salt) in wound care by cesarean section and episiotomy]. | Ivanov, C., et al. 2007. Akush Ginekol (Sofiia). 46 Suppl 4: 20-6. PMID: 19708195
- Structure and dynamics of hyaluronic acid semidilute solutions: a dielectric spectroscopy study. | Vuletić, T., et al. 2010. Phys Rev E Stat Nonlin Soft Matter Phys. 82: 011922. PMID: 20866663
- Efficacy and safety of a low-molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis. | Schlesinger, T. and Rowland Powell, C. 2012. J Clin Aesthet Dermatol. 5: 20-3. PMID: 23125886
- Effects of one-time and two-time intra-articular injection of hyaluronic acid sodium salt after joint surgery in dogs. | Nganvongpanit, K., et al. 2013. J Vet Sci. 14: 215-22. PMID: 23814475
- Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea. | Schlesinger, TE. and Powell, CR. 2013. J Drugs Dermatol. 12: 664-7. PMID: 23839183
- Efficacy and safety of a low molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis final report. | Schlesinger, T. and Rowland Powell, C. 2014. J Clin Aesthet Dermatol. 7: 15-8. PMID: 24847403
- Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment. | Voss, K., et al. 2015. J Control Release. 214: 1-11. PMID: 26160303
- An experimental model of vitreous motion induced by eye rotations. | Bonfiglio, A., et al. 2015. Eye Vis (Lond). 2: 10. PMID: 26613091
- Collagen-based porous scaffolds containing PLGA microspheres for controlled kartogenin release in cartilage tissue engineering. | Sun, X., et al. 2018. Artif Cells Nanomed Biotechnol. 46: 1957-1966. PMID: 29103324
- Hyaluronic Acid Sodium Salt 0.2% Gel in the Treatment of a Recalcitrant Distal Leg Ulcer: A Case Report. | Tagliagambe, M., et al. 2017. J Clin Aesthet Dermatol. 10: 49-51. PMID: 29399261
- A Combined Approach of Double Network Hydrogel and Nanocomposites Based on Hyaluronic Acid and Poly(ethylene glycol) Diacrylate Blend. | Ronca, A., et al. 2018. Materials (Basel). 11: PMID: 30518026
- Combination of hyaluronic acid and PLGA particles as hybrid systems for viscosupplementation in osteoarthritis. | Mota, AH., et al. 2019. Int J Pharm. 559: 13-22. PMID: 30664999
- Mucoadhesive hydrogels for buccal drug delivery: In vitro-in vivo correlation study. | Baus, RA., et al. 2019. Eur J Pharm Biopharm. 142: 498-505. PMID: 31330258
- Laser-induced Forward Transfer Hydrogel Printing: A Defined Route for Highly Controlled Process. | Yusupov, V., et al. 2020. Int J Bioprint. 6: 271. PMID: 33094193
Inhibitor of:
HAPLN2, HAPLN3, and HPSE2_Hpse2.Activator of:
ATIII, Decorin, Laminin α-5, Perlecan, PRELP, and Syndecan-2.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Hyaluronic Acid, Sodium Salt, 100 mg | sc-204004A | 100 mg | $82.00 | |||
Hyaluronic Acid, Sodium Salt, 500 mg | sc-204004 | 500 mg | $235.00 | |||
Hyaluronic Acid, Sodium Salt, 1 g | sc-204004B | 1 g | $360.00 | |||
Hyaluronic Acid, Sodium Salt, 25 g | sc-204004C | 25 g | $700.00 | |||
Hyaluronic Acid, Sodium Salt, 100 g | sc-204004D | 100 g | $1715.00 |